Velcera Pharmaceuticals Inc. announced its formation last week as a new animal health company focused on improving pet medications using unique and proprietary drug delivery technologies.

Dennis Steadman, president and chief executive officer, said, “Velcera is dedicated to breaking through the administration barriers in veterinary medicine to bring new convenience, improved compliance and therapeutic benefits to veterinarian medicines.”

As an example of that dedication, the company separately announced a worldwide license that will provide the technological underpinnings of its current product development program.

“Velcera has combined recognized world-class animal health expertise with a novel, patented drug delivery technology and solid …